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Abstract
The epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptor tyrosine kinases. EGFR is activated
upon binding to e.g. epidermal growth factor (EGF), leading to cell survival, proliferation and migration. EGFR overactivation
is associated with tumor progression. We have previously shown that low dose UVB illumination of cancer cells
overexpressing EGFR prior to adding EGF halted the EGFR signaling pathway. We here show that UVB illumination of the
extracellular domain of EGFR (sEGFR) induces protein conformational changes, disulphide bridge breakage and formation of
tryptophan and tyrosine photoproducts such as dityrosine, N-formylkynurenine and kynurenine. Fluorescence
spectroscopy, circular dichroism and thermal studies confirm the occurrence of conformational changes. An immunoassay
has confirmed that UVB light induces structural changes in the EGF binding site. A monoclonal antibody which competes
with EGF for binding sEGFR was used. We report clear evidence that UVB light induces structural changes in EGFR that
impairs the correct binding of an EGFR specific antibody that competes with EGF for binding EGFR, confirming that the 3D
structure of the EGFR binding domain suffered conformational changes upon UV illumination. The irradiance used is in the
same order of magnitude as the integrated intensity in the solar UVB range. The new photonic technology disables a key
receptor and is most likely applicable to the treatment of various types of cancer, alone or in combination with other
therapies.
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Introduction
The ErbB family of receptor tyrosine kinases (RTKs) plays a key
role in regulating normal cellular processes such as cell survival,
proliferation and migration [1,2] and have a critical role in the
development and progression of cancers [3]. The epidermal
growth factor receptor (EGFR; ErbB1) is a member of this family
[4]. EGFR binding to ligands such as epidermal growth factor
(EGF) or transforming growth factor alpha (TGF-a) leads to
receptor dimerization and to the activation of the intracellular
tyrosine kinase domain [1,2]. The extracellular domain of EGFR
(sEGFR, soluble extracellular region of EGFR) comprises 4 sub-
domains: 2 large homologous binding domains (I and III), and 2
homologous furin-like cysteine rich domains (II and IV). Domains
I, II and III have been found to be directly involved in ligand
binding and dimer formation that precede the mechanism of
signal transduction by RTKs [1,5,6]. Cancer progression has been
correlated with the increase in the number of EGFR molecules on
the cell surface [7]. High expression of EGFR is generally
associated with invasion, metastasis, late-stage disease, chemother-
apy resistance, hormonal therapy resistance and poor general
therapeutic outcome. EGFR overexpression has been found to be
a strong prognostic indicator in head and neck, ovarian, cervical,
bladder and oesophageal cancers, a modest prognostic indicator in
breast, colorectal, gastric and endometrial cancer and a weak
prognostic indicator in non-small-cell lung cancer [7]. EGFR is the
target of many chemotherapeutical approaches because EGFR
activation results in cell signaling cascades that promote tumor
growth. Inhibition of EGFR function is therefore a rational
treatment approach. Typical chemotherapeutical agents are
EGFR tyrosine kinase inhibitors which compete with ATP at
the intracellular tyrosine kinase domain, and monoclonal anti-
bodies (mAbs) that prevent ligand-binding or receptor dimeriza-
tion. Blocking the binding of EGF to EGFR can abolish cancer
proliferation, invasion, metastasis, angiogenesis and inhibition of
apoptosis [8].
We have previously reported that UVB illumination (280 nm,
0.35 W/m2 for 30 min) of cancer cells overexpressing EGFR led
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to the arrest of the EGFR signaling pathway [9]. Proof-of-concept
has been documented on cell lines A431 (human epidermoid
carcinoma cells) and Cal39 (derived from human vulva squamous
cell carcinoma cells). The irradiance used was lower than the total
UVB solar irradiance [10]. UVB prevented EGF induced
activation of EGFR, abolishing phosphorylation of the EGFR
intracellular domain and of other key downstream signaling
proteins such as AKT (Protein Kinase B) and the mitogen
activated protein kinases (ERK1 and 2). AKT plays a key role in
e.g. glucose metabolism, apoptosis, cell proliferation, transcription
and cell migration. AKT is involved in cellular survival pathways
by inhibiting apoptotic processes [11–16]. The ERK kinases act in
a signaling cascade that regulates cellular processes such as
proliferation, differentiation, and cell cycle progression [17].
One of the possible reasons for the observed UV light induced
arrest of the EGFR signaling pathway is the UVB induced
photochemistry, leading to conformational changes in EGFR
which most likely prevent the correct binding to EGF. Our
previous work on UVB induced photochemistry in proteins
(wavelengths used 275–295 nm) [18–22] supports this hypothesis.
UVB excitation of aromatic residues in proteins leads to the
disruption of disulphide bridges and to the formation of
photoproducts, such as N-formylkynurenine (NFK), kynurenine
(Kyn) [23,24] and dityrosine (DT) [25–27] (see Figure 1). Such
reactions will most likely induce structural changes in proteins
which may impair their activity [22]. Proteins that are rich in
aromatic residues and disulphide bridges are likely to have their
structure considerably impaired upon prolonged UVB excitation.
sEGFR is extremely rich in disulphide bridges when compared to
the natural average abundance of disulphide bridges in protein
structures of the size of sEGFR, as will be shown in the results
section. The % of disulphide bridges in sEGFR is approximately
13 times higher than expected for a protein of its size. The
expected average results have been previously reported by our
group after a comprehensive analyses of the features of the
disulphide bridges present in 131 non-homologous single chain
protein structures [28]. Furthermore, the extracellular domain of
sEGFR has 40 aromatic residues and 25 disulphide bridges per
monomer and many of the aromatic residues are in close
proximity of disulphide bridges (see Figure 2). Therefore, it is
likely that UV illumination of this protein will lead to disulphide
bridge breakage and to photoproducts. This hypothesis will be
tested in our present paper.
Whereas the dangers of overexposure to sunlight have been well
publicized, less attention has been given to the health benefits of
UV-exposure. The effects of UV light on biomolecules, cells and
tissues will depend on the energy delivered per unit area. UVB
(280–315 nm) radiation is the primary contributor to vitamin D
production, which has a protective effect in colon, prostate, and
breast cancer [29,30]. Exposure to sunlight in low doses has also
been linked to improved cancer survival rates [31,32]. UV light
has been used to successfully treat rickets, psoriasis, lupus vulgaris,
vitiligo, atopic dermatitis and localized scleroderma and jaundice
(World Health Organization. The known health effects of UV.
Ultrav. Radiat. INTERSUN Program. - FAQ at http://www.
who.int/uv/faq/uvhealtfac/en/index1.html). There is no direct
and conclusive evidence to suggest an increased risk of skin cancer
from UVB treatments for psoriasis if radiation doses are respected.
UV light is currently being used to treat cutaneous T-cell
lymphoma (American Cancer Society, 2011 at http://www.
cancer.org). This therapy has been improved by the Food and
Drug Administration (FDA, USA). The protective effects of
regular weekend sun exposure have been reported, particularly in
the case of limb tumors [33]. Melanoma is more frequent among
people with indoor occupations than among people having
outdoor activities (without sunburn) such as farmers, fishermen,
and kids that play outdoors [34,35]. Skin cancer is still on the
increase but this is a result of exposure to UV light both by acute
overdosing (causing sunburn) and lifelong cumulative exposure
[36]. It is mainly the UVB fraction of solar radiation that gives
erythema, melanogenesis (melanin production, which acts as a
sunscreen protecting against DNA photodamage and erythema),
vitamin D synthesis, and non-melanoma skin cancer, while
melanoma is likely to be caused by UVA [37]. Jones et al (1987)
found that among the UVA wavelengths, 365 nm had the highest
mutagenic effect [38]. UVA fluency rates are several times higher
for sunbeds than in the case of direct solar radiation [39]. The
above examples document that the health effects of UV exposure
are dose and wavelength dependent.
The goal of the present work is to investigate if a low dose of
UVB light can induce structural changes in the EGF binding site
of EGFR that could impair the correct binding of molecules, such
a specific antibody that is known to compete with EGF for EGFR
binding. If observed, this will give us insight into why UVB
illumination (280 nm) of cancer cells overexpressing EGFR led to
the arrest of the EGFR signaling pathway [9]. The UVB
irradiance used is in the same order of magnitude as the total
irradiance of solar UVB. Fluorescence spectroscopy and circular
dichroism studies were carried out in order to detect UVB induced
conformational changes. Thermal unfolding studies have been
done in order to determine the melting point of the protein prior
to and after illumination. Light induced breakage of disulphide
bridges has been quantified and the formation of Trp/Tyr
photoproducts has been detected. A binding immunoassay was
carried out in order to infer the effects of UVB illumination on the
structure of the EGF binding site. Our study confirms that low
dose UVB (280 nm) illumination of sEGFR induced structural
changes in the EGFR binding domain that impaired the binding
of a specific antibody known to compete with EGF for EGFR
binding to that particular domain. We address the beneficial
effects of UV light, its present application in the treatment of
diseases and the potential of our putative new photonic therapy for
the treatment of localized tumors associated with the overexpres-
sion of UV sensitive cellular receptors.
Results
Three-dimensional structure of monomeric and dimeric
sEGFR
In Figure 2A is displayed the 3D structure of monomeric
sEGFR (1ivo.pdb, chain A) bound to Epidermal Growth Factor
(EGF, in red). sEGFR contains 25 SS bridges, 6 Trp residues, 16
Tyr residues, and 18 Phe residues, displayed as CPK: SS bridges in
yellow, Trp in green, Tyr in violet (Tyr246 and Tyr251 in pink)
and Phe in cyan. Only 18 out of 25 SS bridges, 5 out of 6 Trp
residues, 13 out of 16 Tyr residues and 17 out of 18 Phe residues
are displayed since some residues are missing in the pdb file.
Several aromatic residues are located in close spatial proximity of
SS bonds.
In Figure 2B is displayed the 3D structure of the EGFR dimer
(1ivo.pdb, chains A and B) formed upon binding EGF (in red). The
dimer interface is rich in disulphide bridges and aromatic residues
(Fig. 2B). Residues Tyr246 and Tyr251 (Figure 2B, in pink) from
one chain, are intertwined with the same residues from the other
chain. A zoom into one of the chains is displayed in Figure 2C and
distances between aromatic residues and disulphide bridges are
shown. EGF docking to EGFR is displayed in Figure 2D (EGFR
monomer). The interaction between EGFR and EGF appears to
UVB Inactivation of EGFR Blocks EGFR Activation
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be strongly dependent on Van der Waals interactions. Some of
those interactions are p-p interactions, such as the interaction
between Phe357 (in cyan) of sEGFR and Tyr13 (in violet) of EGF
(5 A˚).
Protein Bioinformatics
In Figure 3 is displayed the fraction of disulphide bridges
present in sEGFR and the dependence of the average fraction of
disulphide bridges on the protein chain length [28]. The expected
average fraction of disulphide bridges for proteins with sequence
length of 600–650 residues is,0.3%, while in sEGFR (622 aa) it is
,4%, confirming that this protein is exceedingly rich in disulphide
bridges. The expected average results has been previously reported
by our group after doing a comprehensive analyses of the features
of the disulphide bridges present in 131 non-homologous single
chain protein structures [28].
Steady State Fluorescence
The fluorescence emission intensity of sEGFR at 350 nm
decreases upon continuous 280 nm excitation (Figure 4A). The
kinetic trace is best fitted by a bi-exponential model (Figure 4A
and methods). The root mean square error R2 was 0.99774. The
values recovered from the fitting for C1 and C2 were
367240.4461182.23 and 208449.9561054.90, respectively. The
rate constants of fluorescence emission intensity decrease k1 and
k2 fitted values were 117.6360.71 min-1 and 12.2060.10 min-1,
respectively.
Emission Spectra (excitation 280 nm and
295 nm). Emission spectra of sEGFR were recorded upon
280 nm excitation before and after continuous 280 nm illumina-
tion (15 min, 30 min, 45 min and 75 min at 2.5 W/m2) (not
shown). A decrease in the intensity of the fluorescence emission at
,337 nm, where Trp and Tyr emit, is observed due to continuous
illumination. The emission intensity at 337 nm decreases by 43%
Figure 1. Typical photoproducts generated upon UV illumination of the aromatic residues Trp and Tyr.
doi:10.1371/journal.pone.0111617.g001
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and 74% after 15 min and 75 min of continuous 280 nm
illumination, respectively. The wavelength of the most intense
peak centered at 337 nm remains constant.
The emission spectra of sEGFR recorded upon 295 nm
excitation before and after of continuous 280 nm illumination
(15 min, 30 min, 45 min and 75 min) are shown in Figure 4B. A
decrease in the intensity of the fluorescence emission at ,337 nm,
where Trp emits, is observed. The emission intensity of sEGFR at
337 nm decreases by 42% and 77% after 15 min and 75 min of
continuous 280 nm illumination, respectively. The wavelength of
the most intense peak centered at 337 nm is observed to red-shift
to 343 nm after 75 min of illumination.
Excitation Spectra (emission 334 nm). In Figure 4C is
displayed the excitation spectra of sEGFR with fluorescence
emission fixed at 334 nm, before and after continuous 280 nm
illumination of the protein for different time periods: 15 min,
30 min, 45 min, 60 min and 75 min. Trp and Tyr absorption
contribute to this spectrum. Continuous 280 nm illumination leads
to a progressive decrease in the fluorescence excitation intensity.
After 15 min and 75 min of illumination, the excitation intensity
at 282 nm decreases by 40% and 71%, respectively. The
correspondent normalized excitation spectra (not shown) show
no shift in the wavelength at maximum excitation intensity
(,282 nm).
Figure 2. Structural analysis of the EGFR extracellular domain and interactions with EGF upon dimerization. (A) Crystal structure of
EGFR extracellular domain (1ivo.pdb, chain A) [1]. The disulphide bridges and aromatic residues atoms are displayed as CPK: SS bridges in yellow, Trp
in green, Tyr in violet (Try 246 and Tyr 251 are displayed in pink) and Phe in cyan. Only 18 out of 25 SS bridges, 5 out of 6 Trp residues, 13 out of 16 Tyr
residues and 17 out of 18 Phe residues are displayed since some residues are missing in the pdb file. (B) Crystal structure of a 1:1 complex between
human EGF and the dimeric form of EGFR extracellular domain (1ivo.pdb, chain A and B and 2 EGF molecules [1]). EGF is displayed in red. (C) Zoom
into interface region present in the dimeric of EGFR (extracellular domains). Distances among some of the aromatic residues and the nearby
disulphide bridges are also displayed. (D) Crystal structure of a 1:1 complex between human EGF and the dimeric form of EGFR extracellular domain.
(1ivo.pdb, chain A and B and 2 EGF molecules [1]) EGF is shown in red. In the right panel all atoms are displayed as CPK. EGF docking to sEGFR
involves extensive non-covalent contacts.
doi:10.1371/journal.pone.0111617.g002
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Fluorescence based protein thermal unfolding
studies. The fluorescence emission intensity at 330 nm (exc.
295 nm) of a fresh sEGFR sample (non-illum.) and illuminated
sEGFR sample (75 min at 280 nm) was monitored from 4uC to
90uC and from 90uC to 4uC (see Fig. 5). For both samples the
fluorescence emission intensity decreases upon heating. A transi-
tion between 65–75uC is observed for the non-illuminated sEGFR.
Data has been fitted using a modified Boltzmann function (see
methods). The root mean square error for the fitting R2 was
0.99774. The values recovered from the fitting for A1, B1, A2, B2
and dx were 1.0620260.0014, 0.4548260.02255, 20.004266
5.41E-04, -0.0029662.72E-04 and 1.7460.17, respectively. The
recovered parameter x0 (69.7u60.24uC C) corresponds to the
mid-point of transition, i.e. to the melting temperature of the
protein. This value is in agreement with the inflection point values
obtained from the second derivative of the fitted data (not shown).
The second derivative is zero (inflection point) within the interval
68.3–69.2uC. Such transition is not observed for the illuminated
sample. Furthermore, no transition is observed for both samples
when cooling the protein from 90uC to 4uC.
Time Resolved Fluorescence. The decay times (ti) and pre-
exponential factors (fi) recovered from the time resolved intensity
decays for the control sEGFR sample (75 min in the dark, negative
control, NC) and the illuminated sEGFR sample (illum. for 75 min
Figure 3. Dependence of the average fraction of disulphide
bridges on the protein chain length. The fraction of disulphide
bridges was calculated as the number of disulphide bridges found in a
protein divided by the protein sequence length (number of amino
acids) x 100. The fraction of disulphide bridges present in the
monomeric extracellular domain of EGFR is displayed.
doi:10.1371/journal.pone.0111617.g003
Figure 4. Effects of UV illumination on the intrinsic fluorescence emission of human extracellular EGFR. (A) Fluorescence emission
intensity kinetics at 350 nm of human extracellular EGFR (sEGFR) sample during 75 min UV illumination at 280 nm. (B) Fluorescence emission spectra
of sEGFR samples obtained upon 295 nm excitation after 280 nm illumination for 0 min, 15 min, 30 min, 45 min, 60 min and 75 min. (C)
Fluorescence excitation spectra of sEGFR samples recorded with emission fixed at 334 nm excitation after 280 nm illumination for 0 min, 15 min,
30 min, 45 min, 60 min and 75 min.
doi:10.1371/journal.pone.0111617.g004
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at 280 nm) at pH 7.5 are given in Table 1. Figure 6 shows the
experimental data, the fit and residuals assuming three lifetime
decays for sEGFR control sample (NC). The value of x2 dropped
significantly when progressing from a one lifetime component fit to
two and to three components. The fluorescence mean lifetime of
sEGFR is shown in Table 1. Non-illuminated sEGFR displays
three lifetimes: 1.04 ns, 2.74 ns and 6.23 ns with intensity fractions
of 25.6%, 53.1% and 21.1%, respectively. Upon illumination, the
contribution of the shortest lived 1.04 ns species increased from
25.6% to 30.6%, the contribution of the 2.74 ns species was kept
constant and the contribution of the longer lived species decreased
from 21.1% to 16.4%. Furthermore, the lifetime of the longer
lived component increased from 6.2 ns to 7.0 ns while the lifetime
of the other two components remained constant.
Excitation Spectra (emission 400 nm). In Figure 7A are
displayed the excitation spectra (emission at 400 nm) obtained
before and after continuous 280 nm illumination (0 min, 15 min,
30 min, 45 min, 62 min and 75 min). Spectra were recorded in
order to verify the presence of NFK, dityrosine and Kyn (Fig. 1).
In Table 2 are displayed their absorbance and fluorescence
emission properties. At 0 min, one excitation peak is observed
centered at ,281 nm. Its intensity decays upon UV illumination
of sEGFR, decreasing 52% after 75 min. However, illumination of
sEGFR leads to an increase of fluorescence excitation above
305 nm. After 75 min, fluorescent excitation intensity increased
115% at 315 nm, where dityrosine maximally absorbs (Absmax at
316 nm, [40], see Table 2), 149% at 322 nm, where NFK
maximally absorbs (Absmax at 321 nm, [23], see Table 2) and
173% at 360 nm, where Kyn maximally absorbs (Absmax at
360 nm, [23], see Table 2).
Emission Spectra (excitation 320 nm). In order to verify
the formation of dityrosine (DT) and NFK, emission spectra were
obtained upon 320 nm excitation before and after 280 nm
illumination (Fig. 7B). An increase in fluorescence emission
intensity at 400–405 nm (exc. 320 nm) is observed. The fluores-
cence emission maximum is centered ,400 nm, corresponding to
the emission maximum of DT (Emmax at 400–409 nm, [25,40],
see Table 2) and to a spectral region where NFK can also emit (for
NFK, Emmax at 400–440 nm [23], Table 2). After 75 min,
fluorescence emission intensity at 400 nm increases by 129%. A
small emission peak at ,368 nm is observed in the spectra
Figure 5. Temperature dependent fluorescence emission intensity at 330 nm upon 295 nm excitation. Non illuminated (non illum.) and
UV illuminated (illum. for 75 min) human extracellular EGFR (sEGFR) samples were heated from 4 uC to 90 uC. Fitted values (non-illuminated sample)
were obtained using a modified Boltzmann function (see Results section). The transition mid-point recovered from the fitting was at 69.7260.24uC.
doi:10.1371/journal.pone.0111617.g005
Figure 6. Time-resolved fluorescence measurements. Time-
resolved intensity decay data, fitting curve and residuals obtained
using the ISS routine for the control sEGFR sample (kept in the dark for
75 min, negative control, NC).
doi:10.1371/journal.pone.0111617.g006
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Table 1. Lifetimes (ti) and pre-exponential values (ai) for sEGFR (negative control and UV illuminated samples) at pH 7.5 obtained
by a nonlinear fit (see Figure 6 for example, negative control sEGFR) using the ISS software.
Lifetime (ns) Intensity fraction Pre-exponential
sEGFR Dark for 75 min (negative control, NC)
t1 1.0460.06 f1 0.25860.02 a1 24.8
t2 2.7460.1 f2 0.53160.01 a2 19.4
t3 6.2360.2 f3 0.211 Fixed a3 3.38
,t. f weighed 3.04
sEGFR Illum. for 75 min (at 280 nm)
t1 1.0260.04 f1 0.30660.02 a1 30
t2 2.8860.1 f2 0.5360.01 a2 18.4
t3 7.060.2 f3 0.164 Fixed a3 2.34
,t. f weighed 2.99
doi:10.1371/journal.pone.0111617.t001
Figure 7. Formation of new fluorescence species and changes in thermal unfolding of the human extracellular EGFR upon UV
illumination. (A) Fluorescence emission spectra of human extracellular EGFR (sEGFR) samples recorded upon 320 nm excitation after 280 nm
illumination for 0 min, 15 min, 30 min, 45 min, 60 min and 75 min. (B) Fluorescence emission spectra of sEGFR recorded upon 360 nm excitation
after 280 nm illumination for 0 min, 15 min, 30 min, 45 min and 75 min. (C) Fluorescence excitation spectra of sEGFR obtained with fluorescence
emission fixed at 400 nm after 280 nm illumination for 0 min, 15 min, 30 min, 45 min, 60 min and 75 min.
doi:10.1371/journal.pone.0111617.g007
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obtained at 0 min and 15 min of illumination due to the Raman
contribution of water. Raman spectral corrections did not
completely remove this peak.
Emission Spectra (excitation 360 nm). In order to verify
the presence of kynurenine (Kyn) (Absmax at 360 nm, [23],
Table 2) in sEGFR, emission spectra were obtained upon 360 nm
excitation before and after 15 min, 30 min, 45 min, 60 min and
75 min of 280 nm illumination (Fig. 7C). Kyn absorbs maximally
at 360–365 nm and fluoresces maximally at ,434–480 nm ([23],
Table 2). Continuous UVB illumination of sEGFR leads to an
increase of fluorescence centered at ,430–435 nm. The fluores-
cence intensity at 430 nm increased 53% and 172 after 15 min
and 75 min illumination, respectively.
Thiol group’s quantification
In order to confirm that UV illumination of sEGFR has led to
SS disruption, the concentration of solvent accessible thiol groups
has been determined with the Ellman’s assay for a control sEGFR
sample kept in the dark for 75 min (negative control, NC) and for
a sample previously illuminated at 280 nm for 75 min. The
detected concentration of free thiol groups is 2.9 fold higher in the
illuminated sample (Fig. 8). Free thiol groups in illuminated
sEGFR is ,1 mM.
Circular dichroism studies
In Figure 9A are displayed the CD spectra of fresh sEGFR
(non-illum.) and illuminated sEGFR (75 min at 280 nm). The far-
UV CD spectrum of the non-illuminated sEGFR displays some of
the classical far-UV features of protein secondary structure, with
the presence of a double minimum at 208–210 nm and 220–
222 nm, characteristic of a-helical content. b-sheet structural
content (characteristic minimum at,218 nm) may also contribute
for the second minimum at 220–222 nm [41]. Prolonged
excitation with UVB light leads to a decrease in the ellipticity
intensity at 205–225 nm and to a spectral shift. The ellipticity at
207.5 nm and at 220 nm has decreased by 9% and 20%,
respectively. Furthermore, the first negative peak has shifted from
207.5 nm to 203 nm.
Circular dichroism based protein thermal unfolding
studies. The ellipticity intensity at 220 nm of fresh sEGFR
(non illum.) and of illuminated sEGFR (75 min at 280 nm) was
continuously monitored from 4uC to 90uC (Fig. 9B). For both
samples the ellipticity intensity at 220 nm decreases upon heating.
A transition with mid-point between 60–70 uC is observed for the
non-illuminated sEGFR sample. Data has been fitted by a
Boltzmann function (see methods). The root mean square error
for the fitting R2 was 0.99921. The values recovered from the
fitting for A1, A2 and dx were 20.9669.97E-4, 20.8360.002,
and 2.5960.08, respectively. The temperature of mid-transition x0
fitted value was 64.7060.07 uC, corresponding to the melting
temperature of the protein. This value is in agreement with the
value recovered by fluorescence spectroscopy displayed in
Figure 5. Such transition is not observed for the illuminated
sample.
EGFR binding immunoassay
A binding immunoassay was used to indirectly access the effects
of UV illumination on the structure of the sEGFR binding site to
EGF/TGF-a. Results displayed in Figure 10 show that non-
illuminated sEGFR binds LA1 anti-EGFR (lanes ‘‘No-UV’’, fresh
sample; and ‘‘NC’’, negative control, sample kept in the dark for
75 min). sEGFR sample illuminated with 280 nm light for 75 min
no longer binds LA1 anti-EGFR, confirmed by the complete
disappearance of the sEGFR band (Figure 10, lanes ‘‘UV’’). Two
sets of duplicate samples were analysed. Signal intensity profiles
along the protein bands are shown. The intensity observed in the
regions where illuminated sEGFR was present (‘‘UV’’ lanes) is
within the observed noise level (noise intensity from ,0.02 to 0.2).
Discussion
UVB excitation of aromatic residues leads to the formation of
photoproducts. Tryptophan may form tryptophanyl cation radical,
N-formylkynurenine (NKF) and kynurenine (Kyn) (Fig. 1). NFK
and Kyn are of particular importance as they are photosensitizers
that can generate reactive oxygen species (ROS) upon UV
absorption [42], further contributing to protein structural damage.
Tyrosine residues are known to be converted into e.g. tyrosil
radicals, dityrosine, trityrosine and pulcherosine (Fig. 1). These
reactions are likely to lead to changes or to complete loss of protein
structure and function [22,43]. UVB excitation also leads to
Table 2. Absorption and fluorescence spectral characteristics of N-formylkynurenine (NFK), dityrosine (DT) and kynurenine (Kyn)
[23,25,40].
Absorption (lmax, nm) Fluor. Em. (lmax, nm)
NKF 261, 322 400–440a
DT 284, 316 400–409
Kyn 258, 360 434–480a
aDepending on solvent characteristics (e.g. polarity).
doi:10.1371/journal.pone.0111617.t002
Figure 8. Increase in the concentration of free thiol groups
detected in sEGFR upon UV illumination for 75 min. The control
sample of sEGFR was kept in the dark for 75 min (negative control, NC).
Free thiol groups have been detected using the Ellmann’s assay.
doi:10.1371/journal.pone.0111617.g008
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electron ejection from the side chains of aromatic residues
[20,24,44–46]. The electron can be captured by disulphide
bridges, leading to the formation of a transient disulphide electron
adduct RSSRN- (see schemes 1–8, [49]), which upon dissociation
will form free thiol groups (scheme 9, [47]). Nature has kept
aromatic residues in spatial close proximity to disulphide bridges
Figure 9. Effect of UVB illumination on the far UV circular dichroism features of sEGFR. (A) Far UV CD spectra were recorded for a fresh
sEGFR solution (non illum.) and a sEGFR sample that was previously illuminated at 280 nm (illum. for 75 min). (B) Circular dichroim thermal unfolding
curves of fresh sEGFR (non-illum.) and UVB illuminated sEGFR (illum. for 75 min) were obtained upon heating from 4 uC to 90 uC (1 uC.min21). The
ellipticity signal was constantly monitored at 220 nm. The melting temperature of non illuminated sEGFR, which corresponds to the transition mid-
point of the curve, was recovered upon fitting the curve with a Boltzmann function (see methods).
doi:10.1371/journal.pone.0111617.g009
Figure 10. UV illumination of sEGFR prevents binding of anti-EGFR neutralizer antibody LA1 to its target antigen. In each well, exactly
1.4 mg of non illuminated (‘‘No-UV’’), UV illuminated for 75 min (‘‘UV’’) and negative control (‘‘NC’’) sEGFR samples was loaded. Samples loaded on
well 1–3 are duplicates of samples 4–6, but were treated independently after UV illumination. The intensity profile along the wells shows that signal is
observed in the wells with non-illuminated protein but no signal is present in the wells containing UV illuminated protein samples.
doi:10.1371/journal.pone.0111617.g010
UVB Inactivation of EGFR Blocks EGFR Activation
PLOS ONE | www.plosone.org 9 November 2014 | Volume 9 | Issue 11 | e111617
(SS) in proteins [19,28], making the disruption of SS a likely event
upon UV excitation. The schemes below summarize some of the
photoproducts formed which contribute to SS disruption, leading
to conformation changes that can lead to loss of protein function.
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Proteins rich in aromatic residues and disulphide bridges are
most vulnerable to photochemistry and damage. sEGFR is such a
protein. It has a total of 6 Trp, 16 Tyr, 18 Phe residues and 25
disulphide bridges (Figure 2A). Interestingly, aromatic residues
and disulphide bridges play a critical structural role at the dimer
interface (Figures 2B, 2C, and 2D) indicating that UVB induced
photochemistry will most likely impair EGFR dimerization. The
close proximity between aromatic residues and disulphide bridges
(Figure 2C) promotes electron transfer from the aromatic residues
to the bridges, leading to their disruption. UV-induced protein
inactivation involves fast and short-range electron transfer
between photoexcited aromatic residues and nearby disulphide
bridges [20,44,45,48]. Zhi Li et al. [49] showed that fast electron
transfer is consistent with direct electron transfer between triplet
tryptophan and a nearby disulphide bridge, leading to RSSRN- and
likely bridge breakage (schemes 8 and 9). As displayed in Figure 3,
proteins as large as sEGFR (600–650 aa) are observed to have an
average fraction of disulphide bridges no larger than ,0.3%. This
is presumably due to the stabilizing effect of the large hydrophobic
core. A short protein has a much smaller hydrophobic core and
depends to a larger extent on the structural stability provided by
disulphide bridges. An example of this is insulin, a molecule
formed by two polypeptide chains containing 21 and 30 residues,
respectively, and that has 3 disulphide bridges (SS average fraction
of 5.9%). Two disulphide bridges are the only covalent links
between the chains. sEGFR displays an average SS fraction of
,4% compared to the expected ,0.3%, which means that
disulphide bridges in sEGFR are ,13 times more abundant than
expected for a protein of this length. Due to the fact that
disulphide bridges are good acceptors of the electrons produced
upon UV excitation of the protein, several disulphide bridges
might be disrupted during illumination, compromising the
structure of sEGFR. Data confirms that UVB illumination of
sEGFR leads to the disruption of disulphide bridges (Fig. 8).
Receptors that are not as rich in aromatic residues and
disulphide bridges as EGFR is are known be less sensitive of UV
light. Huang et al. have reported that PDGF receptors did not
appear to be involved in the cells response to UVC illumination,
contrary to what they observed with EGFR [50]. They observed
that PDGF-B was able to stimulate the tyrosine phosphorylation of
the UV illuminated receptor, confirming that the 3D structure of
the PDGFR binding domain remained intact after UV illumina-
tion. PDGFR lower sensitivity to UV light compared to EGFR
might be due to a considerably lower number of disulphide bridges
(3 per monomer) and Trp residues (2 per monomer), and lower
number of aromatic residues in close spatial proximity to
disulphide bridges.
Our previous work on the UV illumination effects on native and
W69A mutant cutinase (Trp-depleted mutant) with 280 nm and
295-nm light also documents the crucial interplay between the
aromatic residue and the disulphide bridge [51]. Cutinase has a
single Trp residue in very close spatial proximity to a disulphide
bridge. 280 nm and 295 nm excitation of theTrp residue is known
the lead to the disruption of the disulphide bridge mediated by an
electron transfer process [20]. This mechanism is severely
impaired in the mutant cutinase. In our present study, the
ultimate control control would be a sEGFR mutant that did not
have aromatic residues and/or disulphide bridges in its structure
or at least that did not have aromatic residues in close spatial
proximity of disulphide bridges. Those mutants are not available
for the simple reason that so many residues would have to be
mutated and most certainly the structure of such mutant would no
longer be the same as the native structure of the extracellular
domain of EGFR. Therefore, studies done with EGFR depleted
mutant cells are important in asserting the important of EGFR in
UV mediated responses. Evidence is found in literature that
strengthens the knowledge that most of the signal pathways
involved in UV-induced processes are thought to originate at
plasma membrane receptors such as EGFR. Zhang et al. showed
that UVA stimulation of the epidermal growth factor receptor
(EGFR) may lead to activation of kinases (p70S6K/p90RSK)
through phosphatidyl isositol (PI)-3 kinase and extracellular
receptor-activated kinases (ERKs) [52]. Evidence is provided that
phosphorylation and activation of p70S6K/p90RSK induced by
UVA were prevented in Egfr-/- cells (in which basal EGFR
expression and its tyrosine phosphorylation induced by UVA were
absent) and were also markedly inhibited by EGFR-specific
tyrosine kinase inhibitors. Hence, data suggest that UVA-induced
p70S6K/p90RSK signalling activation is initiated by EGFR-
dependent pathways. Furthermore, Xu et al. reported that B82
mouse L cells devoid of EGFR confirmed the key role of EGFR in
UVB-dependent signal transduction [53].
Data displayed in Figures 7A, 7B and 7C confirms that UVB
illumination of sEGFR leads to the progressive conversion of Trp
and Tyr residues into species such as NKF, Kyn and DT. The
longer the illumination time the larger such conversion is. Kyn
formation is very clear since it absorbs at 360 nm [23] (Table 2).
Figure 4B confirms that UVB induces conformational changes in
sEGFR due to the observed spectral shift observed upon
illumination (solvent relaxation effect). Such red shift is due to
the fact that the Trp pool in this protein became more solvent
accessible upon illumination. Temperature dependent fluores-
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cence studies (Fig. 5) confirm that illumination of sEGFR induces
conformation changes. Prior to illumination a clear thermal
transition around 69.7uC was observed. Such transition is due to
conformation changes that happen in the Trp moiety of the
protein and is associated with changes in solvent accessibility of
these residues. The transition is absent if the protein previously has
been illuminated for 75 min. This is correlated with the
observation that UV illumination renders Trp residues in sEGFR
more solvent accessible (Fig. 4B). The cooling experiments have
shown that the sEGFR could not refold into its native 3D structure
in our in vitro experiments. It is also likely that protein aggregation
could have occurred upon heating the protein, contributing also to
preventing protein refolding. However, the typical formation of a
turbid solution associated with protein aggregation was not
observed. CD data also confirms that UVB induced protein
conformational changes leading to the loss of secondary structural
content. As can be seen in Figure 9A, UVB illumination lead to
the loss of ellipticity intensity at 207.5 nm (9%) and 220 nm (20%),
characteristic of a-helical content and possibly b-sheet structural
content. It is likely that the large amount of disulphide bridges in
the protein has prevented further loss of ellipticity. The
temperature dependent CD data (Figure 9B) shows that non-
illuminated sEGFR has a melting temperature around 64.7uC.
This value is in good agreement with the value recovered from the
temperature dependent fluorescence studies (69.7uC). After
75 min illumination at 280 nm, the observed transition disap-
pears, confirming that UVB has induced protein denaturation.
The observed structural changes induced in sEGFR as well as the
observed photochemistry are likely causes for the observed
changes in fluorescence lifetime distribution in sEGFR (Table 1).
Conformational changes that alter the environment surrounding
the aromatic residues will most likely induce changes in their
lifetimes’ distribution. The protein immunoassays displayed in
Figure 10 confirm that the UVB illumination of sEGFR induces
structural changes in the EGFR binding site to EGF/TGF-a. After
illumination, sEGFR no longer binds LA1 anti-EGFR antibody,
confirmed by the complete disappearance of the band corre-
sponding to sEGFR (Figure 10). The monoclonal antibody used
competes with EGF and TGF-a for binding to EGFR [54]. This
demonstrates that UV-illumination of sEGFR compromises the
3D structure of the EGF binding site in the protein. EGF docking
to sEGFR is dependent on extensive non-covalent and Van der
Vaals interactions between the two molecules, including p-p
interactions (see Results, Fig. 2D). It is likely that UV induces
conformational changes, disrupting the native tertiary fold that
promotes sEGFR-EGF contacts.
The mechanisms through which EGF binds and induces
receptor dimerization are not fully understood and the standing
model is based on structural studies [1,55,56]. Inactive EGFR is
kept in its closed conformation via interactions between two
sEGFR disulphide rich domains (II and IV) [56]. EGF binding
occurs primarily through interactions with domains I and III
[1,55]. Ligand binding requires a change in the relative positions
of domains I and III and dimerization occurs upon interaction of
subdomains II of two EGFR monomers [1,5,55,56]. It is believed
that domain IV has a role in high affinity binding and signal
transduction [6]. Considering that the mechanisms of EGF
binding and posterior EGFR dimerization can involve all four
domains of sEGFR, it is not surprising that UV induced
conformational changes will most likely impair binding to EGF.
UV induced SS disruption in domain II will likely impair correct
EGFR dimerization, but may also affect EGF binding as it is
involved in the change of the relative position of domains I and III.
Furthermore, domains I and III also contain disulphide bonds,
though in lower extent, and SS breakage in these regions can also
impair EGF binding. It has also been reported by several groups
that EGFR exists as a preformed dimer on the cell-surface [57].
Also in this case, UV induced photochemistry and consequent
structural changes in the EGF binding site will most likely impair
EGF binding.
Our data confirms that low dose UVB leads to conformational
changes in sEGFR, impairing its ability to bind an EGFR specific
antibody that competes with EGF for binding EGFR, confirming
that the 3D structure of the EGFR binding domain suffered
conformational changes upon UV illumination. The present
molecular level in vitro studies allow us to predict that UV light
will most likely also change the structure/function of the
extracellular domain of EGFR when present in the cell surface
of cancer cells overexpressing EGFR, halting this way EGF-EGFR
activation and EGFR dependent key metabolic pathways. Our
most recent studies on the UVB (280 nm) illumination of lung
cancer cells overexpressing EGFR confirm our predictions (paper
in preparation). The present data also supports our previously
publish results showing that low dose UVB illumination of cancer
cells overexpressing EGFR (A431 and Cal39) led to the arrest of
the EGFR signaling pathway [9]. The irradiance used in the
present study (2.5 W.m22) and in the previous study (0.35 W.m22)
is in the same order of magnitude or lower, respectively, than the
total irradiance of sunlight in the UVB region, reported to be
1.75 W.m22 in summer and 0.4 W.m22 in winter (below 313 nm)
[10]. The total amount of energy given to the protein solution after
75 min illumination at 280 nm is 90 mJ. This energy is lower than
the limit values recommended by the British Photodermatology
Group (1000 J, Psoriasis and Psoriatic Arthritis Alliance (PAPAA),
2008, available online at http://www.nhs.uk/ipgmedia/national/
psoriasis) in order to prevent cancer. We envision that low dose
UVB light can be used as a new photonic therapeutical approach
used in order to stop the development of localized cancer, which
cells overexpress EGFR or another receptor which structure will
be labile to UV light. The treatment could be easily applicable to
epidermal skin cancer because UVB light penetrates the skin down
to 150–200 mm [37] (online information from the Department of
Dermatology School of Medicine, University of California, San
Francisco. UV Radiation. at http://www.dermatology.ucsf.edu/
skincancer/General/prevention/UV_Radiation.aspx). The thick-
ness of the stratum corneum of our skin is 10–20 mm, the thickness
of the epidermis can vary from 50 to 150 mm [37] (online
information from the Department of Dermatology School of
Medicine, University of California, San Francisco. UV Radiation.
at http://www.dermatology.ucsf.edu/skincancer/General/
prevention/UV_Radiation.aspx) while the thickness of the dermis
varies from 30 to 300 mm (Brannon, H. Skin Anatomy. at http://
dermatology.about.com/cs/skinanatomy/a/anatomy.htm). If the
localized tumor is located deeper location, UVB light could be
delivered to those locations my means of an optical fiber or
generated via multiphoton excitation using e.g. IR light. This
possible new photonic therapy can also be applied during a
surgical intervention.
The role of UV light on the activation or deactivation of EGFR
and in promoting cell death or cell survivel remains controversial.
We have previously described the attenuation of EGFR signaling
as detected by the phosphorylation status of key downstream
molecules i.e. AKT and the mitogen activated protein kinases
ERK1 and 2 [9]. In response to UV (280 nm) illumination
phosphorylation of AKT and ERK1/2 is not detectable upon
activation with EGF. Given the observed upregulation of
p21WAF1 in our previous work [9], which is a cyclin dependent
kinase inhibitor, we must assume that UV illumination causes the
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cells to arrest the cell cycle in G1 phase, which would be beneficial
in inhibiting the proliferative potential of EGFR overexpressing
cells. Adachi S. et al have also recently shown that UV irradiation
can induce evasion of colon cancer cells from stimulation of
epidermal growth factor [58]. They report that UV (254 nm)
caused inhibition of cell survival and proliferation, concurrently
inducing the decrease in cell surface EGFR and subsequently its
degradation. Furthermore, the same team has reported that UV
(254 nm) significantly inhibited platelet-derived growth factor
PDGF-BB-induced phosphorylation of Akt on pancreatic cancer
cells [59]. Several reports exist, describing how UV light can
activate the EGF receptor hence activating the AKT and MAPK
pathway (43–50 from ref. 9). These observations are in contrast to
our results. Wan et al. have reported that UVB irradiation
stimulated PI 3-kinase activity in human skin in vivo [60]. UV also
stimulated phosphorylation of the downstream AKT effectors, S6
kinase and BAD. Inhibitors of EGFR and PI 3-kinase blocked UV-
induced phosphorylation of BAD, suggesting that EGFR mediates
UV-activated cell survival pathway. They concluded that both
positive and negative roles for UV activation of the PI 3-K/AKT
pathway in human skin can be envisioned. The PI 3-K/AKT
pathway likely plays a critical role in balancing UV-induced
apoptotic signals, thereby preventing widespread skin cell death.
Conversely UV activation of the PI 3-K/AKT pathway may
enhance survival of mutated cells, thereby promoting skin cancer,
as has been found in several other types of cancer. Cao et al. [61]
have concluded that UV (.290 nm, UVB/UVA2 source peaking
we believe at 445 nm) induces multiple signalling pathways
mediated by EGFR trans-activation leading to possible matura-
tion, apoptosis and survival, and EGFR activation protects against
UV-induced apoptosis in cultured mouse dendritic cells. Authors
also report that most of the UV responses are mediated by the
production of reactive oxygen species (ROS) and can be blocked
by antioxidants. UVC is reported to induce rapid and transient
expression of early growth response-1 gene (Egr-1) encoding a
transcription factor that plays a role in cell survival. UVC
irradiation causes tyrosine phosphorylation of EGFR in mouse
NIH 3T3 fibroblasts and HC11 mouse mammary cells [50].
Possible reasons for the reported discrepancies could be found in
the wavelength used in the experiments (from 254 nm to 445 nm),
in the illumination power per unit of illuminated area and in the
type of cells used (mutated vs non-mutated cells). Unfortunately
these values are not accurately reported in all papers in order to
make comparisons possible.
The present paper has provided unequivocal evidence for a
UVB induced structural modification in EFGR, resulting in
structural changes in the EGF binding site and loss of function.
Interestingly, these changes were observed at a photonic power
level approximately in the same order of magnitude as the
integrated power in the solar UVB range. Therefore, it is
reasonable to believe that UVB possesses therapeutic properties,
especially towards skin and other superficial types of cancer.
Clearly there must be a threshold irradiance level and illumination
time, below which UVB light can be used for cancer treatment.
Our most recent studies on the on the UV (280 nm) effects on
EGF-EGFR activation of A549 lung carcinoma cells overexpress-
ing EGFR (paper in preparation) confirm the hypothesis raised in
this study that 280 nm light will most likely also change the
structure/function of the extracellular domain of EGFR when
present in the cell surface of cancer cells overexpressing EGFR,
preventing this way EGF-EGFR binding and activation.
Materials and Methods
Structure Analysis
The crystallography data used for the display of the 3D protein
structure (Figure 2) was extracted from 1ivo.pdb (extracellular
domain of human epidermal growth factor receptor complexed
with EGF, 3.3 A˚ resolution [1]). Accelrys Discovery Studio
Visualizer 3.5 was used for displaying the 3D structure. Distances
between protein residues were obtained by using the monitor tool
in the program to determine the distance between atoms in the 3D
structure. The fraction of disulphide bridges was calculated as the
number of disulphide bridges found in a protein divided by the
protein sequence length (number of amino acids) x 100 (Figure 3).
The pdb dataset used in order to display the dependence of the
average fraction of disulphide bridges on the protein chain length
has been published previously by our group [28].
Fluorescence Studies
Fluorescence studies were carried out in order to analyze the
effects of 280 nm excitation on the structure of the extracellular
domain of human EGFR (sEGFR). sEGFR was purchased from
Speed Biosystems (YCP1031). This protein was expressed in
human embryonic kidney (HEK) 293 cells. The amino acid
sequence corresponds to sEGFR (Leu25-Ser645) with a C-
terminal polyhistidine (His) tag. The protein was dissolved directly
in 10 mM Sodium Phosphate Buffer (NaPB) at pH 7.5 (stock
solutions). Milli-Q water with conductivity below 0.2 mS.cm21 was
used. sEGFR concentration was determined by Abs280nm using a
molar extinction coefficient of 60,000 M21cm21 estimated using
the bioinformatic tool ProtParam (Expasy, [62], entry: sequence of
extracellular domain of EGFR (Leu25-Ser645) with a C-terminal
polyhistidine (His) tag). Stock solutions were used within 2-3 days
after dissolution in buffer and was kept desiccated and protected
from light at 4uC. Before each experiment the stock solution was
diluted to 3.9 mM. Unless stated otherwise, this was the
concentration used in all the fluorescence studies.
Steady state studies
UVB illumination of sEGFR was carried out in a ChronosBH
spectrometer (ISS) with a T-configuration, using a 300-W Xenon
arc lamp coupled to a monochromator. Excitation and emission
slits were set to 4 nm and 8 nm, respectively. Lamp power at the
sample location was 89 mW (at 280 nm). The illumination spot
was 0.35 cm2. Irradiance was 2.5 W.m22. The temperature of the
solution was kept at 20uC using a Peltier element at the cuvette
holder location. One hundred L of sEGFR stock solution was
placed in a quartz cuvette (2 mm610 mm66 mm excitation
volume) and excited at 280 nm during a maximum time of
75 min. Samples were illuminated through the 2 mm66 mm
window and fluorescence collected from the 10 mm66 mm
window. A fresh sample was used for each illumination session.
Emission spectra were acquired with 280 nm, 295 nm, 320 nm
and 360 nm excitation. Excitation spectra were recorded with the
emission fixed at 320 nm, 334 nm, 350 nm, and 400 nm. Each of
the previous spectra was recorded before illumination (0 min), and
after 15 min, 30 min, 45 min, 60 min and 75 min of illumination.
The same emission and excitation spectra were acquired for the
buffer. The emission and excitation intensity values obtained were
corrected in real-time for oscillations in the intensity of the
excitation lamp. Buffer Raman signal was subtracted from each
emission spectrum. The 350 nm fluorescence emission intensity
upon continuous 280 nm excitation was recorded during 75 min
of illumination.
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Fluorescence based protein thermal unfolding
studies. Trp emission is sensitive to the extent of solvent
accessibility. The more solvent accessible Trp is the more red
shifted its fluorescence emission will be. Therefore, Trp emission is
usually used as a probe for protein conformational changes and
can be used to determine the melting temperature of the protein.
The 330 nm fluorescence emission intensity (exc. 295 nm) of a
fresh sEGFR sample (3.49 mM) and of a 280 nm illuminated for
75 min sEGFR sample (3.07 mM) was monitored from 4 uC to 90
uC. The sEGFR sample was continuously illuminated at 280 nm
and as it was previously described. The heating rate was 1uC/min.
A point was acquired every minute. After reaching 90 uC the
protein samples were cooled from 90 uC to 4 uC at a cooling rate
of 1 uC/min and the fluorescence intensity at 330 nm was
monitored (exc. 295 nm).
Time resolved studies. A sEGFR sample was continuously
illuminated at 280 nm during 75 min. The experimental set-up
and parameters used for UVB illumination were the same as
previously described. As negative control, a freshly prepared
sEGFR sample was kept in the dark for 75 min. After UV
illumination or dark period (negative control), the sample was kept
in the cuvette and lifetime measurements were carried out at
magic angle conditions using TCSPC method. A 283 nm light
emitting diode from ISS (FWHM = 9 nm) was used to excite the
samples. The fluorescence emission at magic angle (54.7u) was
counted by a GaAs detector (Hamamatsu H7422P-40), and a
300 nm long-pass filter (Semrock) was employed in order to stray
light. A solution of Ludox in Millipore water was used as a
reference sample. The instrument response function for this system
is 180 ps.
Detection of thiol groups’ concentration formed upon
UV illumination of sEGFR
Preparation of sEGFR solutions and buffers was carried as
described in the previous section. One hundred L of sEGFR work
solution (3.9 mM) was placed in a quartz macro cuvette (1 cm path
length) and illuminated at 280 nm during 75 min. 280 nm
illumination was carried out as described in the previous section.
In parallel, 100 mL of the same sEGFR work solution was kept in
the dark for 75 min (negative control sample, dark NC). Ellman’s
assay was used in order to detect free thiol groups formed upon
UVB induced disruption of disulphide bridges in sEGFR
[19,21,22,63]. Ellman’s reagent, 5,59-dithiobis-2-nitrobenzoic acid
(DTNB) was purchased from Molecular Probes (product D8451,
Life Technologies, Naerum, Denmark). One hundred mM stock
solution was prepared in DMSO and stored at 4uC. After
illumination, 150 mL of 2 times diluted illuminated or control
sEGFR solution was mixed with an excess of DTNB (1.5 mL of
100 mM stock solution). The molar ratio DTNB/sEGFR was
5.13. Four minutes after mixing the two components (sample kept
in the dark), the absorbance intensity at 412 nm was measured in a
UV/Visible spectrophotometer (Shimadzu Corporation, 3.
Kanda-Nishikicho 1-chome, Chiyoda-ku, Tokyo 101–8448, Ja-
pan), using a 1 cm path length quartz cuvette. The product of the
reaction is the 2-nitro-5-thiobenzoate ion (TNB22), which absorbs
at 412 nm. Abs412nm is proportional to the amount of thiol groups
present in solution. The concentration of thiol groups was
determined using an extinction molar coefficient for TNB22 of
14150 M21.cm21 at 412 nm [63].
Circular dichroism studies
The circular dichroism spectrum of a fresh sEGFR sample and
of a 280 nm illuminated for 75 min sEGFR sample was acquired
in order to monitor the UVB loss of secondary structural elements.
Preparation of sEGFR solutions and buffers was carried as
previously described. One hundred mL of sEGFR work solution
(3.9 mM) was placed in a quartz macro cuvette (1 cm path length)
and illuminated at 280 nm during 75 min. The experimental set-
up, conditions and parameters used during the illumination
procedure were the same as previously described. Immediately
after the illumination, 200 mL of 3 times diluted illuminated
sEGFR solution was placed in a quartz microcuvette with a path
length of 0.1 cm and cooled to 4uC using a Peltier element at the
cuvette holder’s location. Afterwards, a far-UV CD spectrum was
recorded. Temperature was kept constant at 4uC during the
measurement. The same was done for a fresh sEGFR sample. Far-
UV CD spectra (190–240 nm) were acquired using the following
parameters: 1.0 nm band width, resolution 0.5 nm, 4 accumula-
tions, scan speed 20 nm/min, sensitivity high, 16 s response time.
Far-UV CD spectrum was also acquired for the buffer. The buffer
signal was subtracted from all spectra. The measurements were
carried out on a JASCO J-815 CD spectrometer (JASCO
Corporation, Ishikawa-cho Hachioji-shi, Tokyo, Japan).
Circular dichroism based protein thermal unfolding
studies. The ellipticity intensity at 220 nm of a fresh sEGFR
sample and of a 280 nm illuminated for 75 min sEGFR sample
(both solutions 3.9 mM) was continuously monitored from 4uC to
90uC. The experimental set-up, conditions and parameters used
during the illumination procedure were the same as described in
the previous sections. The heating rate was 1 uC/min. A point was
acquired every minute. Far-UV CD spectra (190–240 nm) were
acquired at 4uC (before heating) and at 90uC. Afterwards the
protein samples were cooled from 90uC to 4uC at a cooling rate of
1 uC/min and the ellipticity intensity at 220 nm was monitored
every minute. At the end, far-UV CD spectra (190–240 nm) were
acquired at 4uC. Far-UV CD spectra (190–240 nm) were recorded
using the parameters described in the previous section.
Immunoassay
A binding immunoassay was carried out in order to analyze the
effects of 75 min of UV illumination at 280 nm on the structure of
the EGF-sEGFR binding site. The primary mouse monoclonal
antibody anti-EGFR neutralizer antibody LA1 from Milipore (05–
101), which competes with EGF and TGF-a for binding EGFR
[54] was used.
For each experiment, 1.4 mg of fresh non-illuminated protein
sample, 1.4 mg of a 280 nm illuminated sample for 75 min and
1.4 mg of a protein sample that has been in the dark for 75 min
(negative control, NC) were analyzed by Western blot. The
experimental set-up, conditions and parameters used during UV
illumination procedure were the same as described in the previous
sections. Samples were resolved by reduced sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE), 7.5% polyacryl-
amide from Bio-Rad (4561023) and transferred to a 0.2 mm
nitrocellulose membrane from Whatman (10402495). Then, the
membrane was probed with 11000 dilution of LA1 primary
antibody followed by incubation with 15000 dilution of goat anti-
mouse horseradish peroxidase (HRP)-conjugated secondary anti-
body from Santa Cruz Biotech (SC-2005). Immune complexes
were visualized on nitrocellulose by enzyme-linked enhanced
chemiluminescence (ECL) from GE Healthcare (RPN2232) and
detected using the CCD camera of G:Box chemi XT4 controlled
by Genesys software from Syngene. Band intensities were
quantified using the gel analysis software GeneTools from
Syngene. The immunoassay was carried out twice.
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Data Analysis
All data analysis, plotting and fitting procedures were done
using Origin 8.1.
Emission Spectra and Excitation Spectra. Emission Spec-
tra (280 nm, 295 nm, 320 nm, and 360 nm excitation) were first
smoothed using a 12 points adjacent averaging. Excitation Spectra
(emission fixed at 334 nm and 400 nm excitation) were smoothed
using a 5 points adjacent averaging. All fluorescence spectra
obtained were first Raman corrected by subtracting the spectra
recorded for the buffer in solution. Normalized emission and
excitation spectra were obtained by dividing each data point by
the maximum intensity value in each spectrum.
Fitting Procedures. Fluorescence emission kinetic trace at
350 nm upon 280 nm exc: The fluorescence emission kinetic trace
(em. 350 nm, Fig. 4A) was fitted using a bi-exponential function
F(t)= y0 + C1.e-k1.t + C2.e-k2.t. F(t) is the fluorescence emission
intensity at 350 nm (a.u.) at 280 nm excitation time t (min), y0, C1
and C2 are constants and k1 and k2 is the rate constant of
fluorescence emission intensity decrease (min-1). y0 value was fixed
to 0.
Fluorescence based protein thermal unfolding studies: The
fluorescence emission intensity thermal curves (Fig. 5) were first
smoothed using a 5 points adjacent averaging. The fluorescence
emission intensity values were afterwards normalized by dividing
each value by the initial 330 nm emission intensity value. The
curve corresponding to the non-illuminated sEGFR sample (non







where y (a.u.) is the 330 nm fluorescence emission intensity at the
temperature x (uC), A1, B1, A2, B2 and dx are constants. The
fitting parameter x0 (uC) corresponds to the inflection point of the
Boltzmann curve and the corresponding temperature is the
temperature of mid-transition determined upon probing Trp
fluorescence emission.
Fluorescence lifetimes: The fluorescence decay was analyzed by
an ISS routine based on the Marquardt least-squares minimiza-
tion. The governing equations for the time-resolved intensity
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where F(t) is the intensity decay, ai is the amplitude (pre-
exponential factor), ti the fluorescence lifetime of the i-th discrete
component, and g ai = 1.0.










Circular dichroism based protein thermal unfolding
studies. Only the data values obtained above 10uC were then
considered for analysis. The ellipticity intensity values were first
smoothed using a 12 points adjacent averaging. The data values
were then normalized by dividing each ellipticity intensity value by
the initial ellipticity intensity value (i.e. first data point above
10uC). The curve corresponding to the non-illuminated sEGFR







where y (a.u.) is the 220 nm ellipticity intensity values at the
temperature x (uC), A1, A2, and dx are constants. The fitting
parameter x0 (uC) is the inflection point of the Boltzmann curve
and its value corresponds to the temperature of mid-transition of
the curve. The fitting was done for the interval 57.12–69.48uC,
which comprises the thermal transition part of the curve.
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